SE457084B - N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav - Google Patents

N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav

Info

Publication number
SE457084B
SE457084B SE8201311A SE8201311A SE457084B SE 457084 B SE457084 B SE 457084B SE 8201311 A SE8201311 A SE 8201311A SE 8201311 A SE8201311 A SE 8201311A SE 457084 B SE457084 B SE 457084B
Authority
SE
Sweden
Prior art keywords
aza
methyl
deoxo
dihydroerythromycin
hydrogen
Prior art date
Application number
SE8201311A
Other languages
English (en)
Swedish (sv)
Other versions
SE8201311L (sv
Inventor
G Kobrehel
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25550598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE457084(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of SE8201311L publication Critical patent/SE8201311L/
Publication of SE457084B publication Critical patent/SE457084B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8201311A 1981-03-06 1982-03-03 N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav SE457084B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU592/81A YU43006B (en) 1981-03-06 1981-03-06 Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof

Publications (2)

Publication Number Publication Date
SE8201311L SE8201311L (sv) 1982-09-07
SE457084B true SE457084B (sv) 1988-11-28

Family

ID=25550598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8201311A SE457084B (sv) 1981-03-06 1982-03-03 N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav

Country Status (19)

Country Link
US (1) US4517359A (fr)
JP (1) JPS5858357B2 (fr)
AT (1) AT375945B (fr)
BE (1) BE892357A (fr)
CA (1) CA1191843A (fr)
CH (1) CH655728A5 (fr)
CZ (1) CZ418991A3 (fr)
DD (1) DD202437A5 (fr)
DE (1) DE3140449C2 (fr)
FR (1) FR2501212B1 (fr)
GB (1) GB2094293B (fr)
HU (1) HU186845B (fr)
IT (1) IT1200960B (fr)
PL (2) PL133764B1 (fr)
SE (1) SE457084B (fr)
SI (1) SI8110592A8 (fr)
SK (1) SK418991A3 (fr)
SU (1) SU1287755A3 (fr)
YU (1) YU43006B (fr)

Families Citing this family (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4492688A (en) * 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
EP0132026B1 (fr) * 1983-05-23 1986-12-30 Pfizer Inc. Ethers cycliques à activité antibactérielle, de 9-déoxy-9a-aza-9a-homoérythromycine et produits intermédiaires
JPS59225198A (ja) * 1983-05-23 1984-12-18 フアイザ−・インコ−ポレ−テツド 抗菌性を有する９―デオキソ―９ａ―アザ―９ａ―ホモエリスロマイシンＡ，その製造方法および組成物
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (fr) * 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6017894A (en) * 1988-08-03 2000-01-25 Schering Corporation Actinomadura fulva subsp uruguayensis and antimicrobial complex and antimicrobial compounds isolated therefrom
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
TW271400B (fr) * 1992-07-30 1996-03-01 Pfizer
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
DE69403963T2 (de) * 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CZ292360B6 (cs) * 1994-05-06 2003-09-17 Pfizer Inc. Dávkovací forma s řízeným uvolňováním obsahující azithromycin a způsob její výroby
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
ATE267835T1 (de) * 1997-10-16 2004-06-15 Pliva Pharm & Chem Works Neue 9a-azalide
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
TW546302B (en) 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
CA2245398C (fr) * 1998-08-21 2002-01-29 Apotex Inc. Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention
WO2000017218A1 (fr) 1998-09-22 2000-03-30 Pfizer Products Inc. Antibiotiques carbamates et carbazates cetolides
JP4043191B2 (ja) * 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
EP1152765B1 (fr) 1998-11-30 2004-10-13 Teva Pharmaceutical Industries Ltd. Ethanolate d'azithromycine, procede de fabrication, et compositions pharmaceutiques en contenant
EP1137654A1 (fr) 1998-12-10 2001-10-04 Pfizer Products Inc. Antibiotiques a base de cetolides de carbamate et de carbazate
EP1147121B1 (fr) * 1999-01-27 2003-12-17 Pfizer Products Inc. Antibiotiques cetolides
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
WO2000071557A1 (fr) * 1999-05-24 2000-11-30 Pfizer Products Inc. Derives de 13-methyl-erythromycine
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
EP1101769A3 (fr) 1999-11-18 2001-10-24 Pfizer Products Inc. Dérivés de l'érythromycine contenant de l'azote
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
US6586576B2 (en) 2000-01-04 2003-07-01 Teva Pharmaceutical Industries Ltd Preparation method of azithromycin hydrates
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10030781A1 (de) * 2000-06-29 2002-01-17 Hassan Jomaa Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
DE60026718T2 (de) 2000-07-25 2006-11-16 Laboratorio Silanes, S.A. De C.V. Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
EP1313749B1 (fr) * 2000-08-23 2005-10-12 Wockhardt Limited Procede de preparation d'azithromycine anhydre
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
SK287814B6 (sk) 2000-11-27 2011-11-04 Sandoz Ag Azithromycin in the form of a monohydrate, a process for its preparation and pharmaceutical compositions comprising same
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
MXPA03009786A (es) 2001-04-27 2004-01-29 Pfizer Prod Inc Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-sustituidos.
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EA007618B1 (ru) * 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
CZ2004232A3 (cs) * 2001-08-21 2005-10-12 Pfizer Products Inc. Jednorázová dávka azithromycinu
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
US6764997B2 (en) * 2001-10-18 2004-07-20 Teva Pharmaceutical Industries Ltd. Stabilized azithromycin compositions
EP1530505A4 (fr) * 2001-11-30 2007-09-12 Bristol Myers Squibb Co Configurations de pipettes et jeux de pipettes pour mesurer des proprietes electriques cellulaires
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483277A4 (fr) 2002-02-15 2007-10-03 Merckle Gmbh Conjugues de composes biologiquement actifs, procedes de preparation et d'utilisation, et formulation et applications pharmaceutiques
AU2003215245A1 (en) * 2002-02-15 2003-09-09 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP2266590A3 (fr) 2002-02-22 2011-04-20 Shire LLC Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
WO2003072589A1 (fr) * 2002-02-26 2003-09-04 Meiji Seika Kaisha, Ltd. Nouveau compose azalide cyclique a 15 chainons, nouveau derive diazalide cyclique a 16 chainons et procede de production de ceux-ci
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
US20040043073A1 (en) * 2002-06-14 2004-03-04 Chih-Ming Chen Pharmaceutical compositions for drugs having pH-dependent solubility
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
CA2520192A1 (fr) * 2003-03-25 2004-10-14 Teva Pharmaceutical Industries Ltd. Produits de degradation de l'azithromycine, et methodes permettant de les identifier
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
PL1638529T3 (pl) * 2003-06-16 2017-03-31 Andrx Pharmaceuticals, Llc. Kompozycja doustna o przedłużonym uwalnianiu
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate
CA2533178C (fr) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Produit antibiotique, son utilisation et sa formulation
CA2533292C (fr) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Produit antibiotique, utilisation et formulation correspondantes
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (fr) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Pastille robuste
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JPWO2005019238A1 (ja) * 2003-08-22 2006-10-19 明治製菓株式会社 新規アザライド及びアザラクタム誘導体とその製造法
WO2005023184A2 (fr) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Produit antibiotique, son utilisation et sa formulation
CA2538064C (fr) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
WO2005030227A1 (fr) * 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. Derives 9a-azalide 11-3c-bicycliques
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
ES2308274T3 (es) * 2003-12-04 2008-12-01 Pfizer Products Inc. Procedimiento para fabricar multiparticulados farmaceuticos.
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
WO2005053652A1 (fr) 2003-12-04 2005-06-16 Pfizer Products Inc. Compositions medicamenteuses cristallines multiparticulaires contenant un poloxamere et un glyceride
WO2005053639A2 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Formes multiparticulaires a liberation controlee produites avec des optimiseurs de dissolution
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
CA2547597A1 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Compositions multiparticulaires a stabilite amelioree
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006011160A1 (fr) * 2004-06-28 2006-02-02 Alembic Limited Procede pour la preparation de clathrate d'isopropanol d'azithromycine monohydrate
EP1771158A4 (fr) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Comprimé pour distribution par impulsion
WO2006004085A1 (fr) * 2004-07-02 2006-01-12 Wakamoto Pharmaceutical Co., Ltd. Composition médicinale à base d'eau contenant de l'azithromycine et procédé servant à préparer celle-ci
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
BRPI0519135A2 (pt) 2004-12-21 2008-12-23 Pfizer Prod Inc macrolÍdeos
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
KR20090042971A (ko) 2006-08-24 2009-05-04 욱크하르트 리서치 센터 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
US8293715B2 (en) * 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US20090062220A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched azithromycin
US8299035B2 (en) * 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
PL2344129T3 (pl) 2008-10-07 2018-07-31 Horizon Orphan Llc Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
US20170128481A9 (en) 2009-03-06 2017-05-11 Insite Vision Corporation Ocular treatment with reduced intraocular pressure
WO2011015219A1 (fr) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Procédé de purification d'azithromycine par séparation de ses produits de dégradation thermiques et/ou isomères
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
US9175031B2 (en) 2010-12-09 2015-11-03 Wockhardt Limited Ketolide compounds
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
EP2688900B1 (fr) 2011-03-22 2016-09-28 Wockhardt Limited Procédé de préparation de composés de cétolides
WO2013088274A1 (fr) 2011-12-14 2013-06-20 Wockhardt Limited Composition d'azithromycine amorphe anhydre dépourvue de dihydrate d'azithromycine
US10987370B2 (en) 2012-12-24 2021-04-27 Ramot At Tel-Aviv University Ltd. Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin
US9044508B2 (en) 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN104910222B (zh) * 2015-06-29 2018-02-13 石药集团欧意药业有限公司 阿奇霉素新晶型化合物及其制备方法
CN105061528B (zh) * 2015-08-05 2017-10-17 浙江维康药业股份有限公司 一种阿奇霉素化合物及含有该化合物的阿奇霉素软胶囊
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681326A (en) * 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4283527A (en) * 1980-04-01 1981-08-11 Pfizer Inc. Erythromycylamine 11,12-carbonate and derivatives thereof

Also Published As

Publication number Publication date
YU59281A (en) 1983-06-30
SE8201311L (sv) 1982-09-07
PL235329A1 (fr) 1982-09-27
AT375945B (de) 1984-09-25
SK418991A3 (en) 1995-07-11
IT8267263A0 (it) 1982-03-05
HU186845B (en) 1985-09-30
GB2094293B (en) 1985-12-18
CH655728A5 (de) 1986-05-15
GB2094293A (en) 1982-09-15
FR2501212B1 (fr) 1985-08-09
DE3140449A1 (de) 1983-10-13
SI8110592A8 (en) 1996-06-30
FR2501212A1 (fr) 1982-09-10
ATA440081A (de) 1984-02-15
PL131784B1 (en) 1985-01-31
BE892357A (fr) 1982-07-01
IT1200960B (it) 1989-01-27
US4517359A (en) 1985-05-14
JPS57158798A (en) 1982-09-30
JPS5858357B2 (ja) 1983-12-24
CA1191843A (fr) 1985-08-13
SU1287755A3 (ru) 1987-01-30
DD202437A5 (de) 1983-09-14
PL133764B1 (en) 1985-06-29
CZ418991A3 (en) 1993-01-13
DE3140449C2 (de) 1984-06-20
YU43006B (en) 1989-02-28

Similar Documents

Publication Publication Date Title
SE457084B (sv) N-metyl-11-aza-10-deoxo-10-dihydroerytromycin a och derivat samt foerfarande foer framstaellning daerav
DK172636B1 (en) 6-o-methylerythromycin a derivative
DE69305987T2 (de) 5-0-desosaminylerythronolide a derivate
US4331803A (en) Novel erythromycin compounds
US5250518A (en) O-methyl derivatives of azithromycin A
US4464527A (en) Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
US4150220A (en) Semi-synthetic 4"-erythromycin A derivatives
JPS58159499A (ja) 抗菌剤として有用な４″−エピエリスロマイシンａおよびその誘導体
US3674773A (en) Erythromycin derivatives
US4017607A (en) 9,3",4"-Triacyl ester of the antibiotic SF-837 M1 substance and the production thereof
HU211975A9 (en) Derivatives of tylosin and 10,11,12,13-tetrahydrotylosin and their use in pharmaceuticals
CH642381A5 (de) Dialkanoyltylosinderivate.
US4476298A (en) Erythromycin A derivatives
GB1585315A (en) Erythromycin a derivatives
US4880825A (en) Mitomycin derivatives
US4360683A (en) Antibiotic nodusmicin derivatives
US3855202A (en) One step process for the production of a monoester of macrolide antibiotics
US4363922A (en) Esters of antibiotic nodusmicin
KR0158692B1 (ko) 항생물질 ll-e19020 알파 및 베타의 화학적 유도체
EP0394907A1 (fr) Procédé pour la production d'étoposides
EP0114486A2 (fr) Alkylation d'oléandomycine
DE2462053C3 (de) Isopurpuromycin, Pentaacetylisopurpuromycin, Verfahren zur Herstellung von Pentaacetylisopurpuromycin und diese Verbindung enthaltende Arzneimittel
US4603212A (en) Analogs of the antibiotic spectinomycin
US3959256A (en) 9-O-Alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance and the production thereof
CH658660A5 (de) 3-0-acyl-4''-deoxydesmycosin-derivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 8201311

NAL Patent in force

Ref document number: 8201311-1

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490101, 920703, EXPIRES: 20060403

SPCG Supplementary protection certificate granted

Free format text: 9490101, 920703, EXPIRES: 20070303

NUG Patent has lapsed

Ref document number: 8201311-1

Format of ref document f/p: F